Performance analysis of Regulus Therapeutics (RGLS)
Annual Return
Over the past 3 years, RGLS has had an average annual return of +142.73%, outperforming the benchmark SPY, which returned +20.39% annual.
Over the past 5 years, RGLS has had an average annual return of -7.32%, underperforming the benchmark SPY, which returned +10.96% annual.
Over the past 10 years, RGLS has had an average annual return of -38.84%, underperforming the benchmark SPY, which returned +14.30% annual.
Since Oct 9, 2012, RGLS has had an average annual return of -27.94%, underperforming the benchmark SPY, which returned +13.99% annual.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| +416.67% | +25% | -7.69% | -56.67% | -76.65% | +52.07% | -4.52% | -92.54% | -53.79% | -74.20% | -45.64% | +117.05% |
| 2013 | 2012 | ||||||||||
| +17.30% | +43.84% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -36.67% | +36.84% | +26.92% | +360.61% | -0.66% | +2.65% | +416.67% | ||||||
| 2024 | -0% | +16.67% | +96.43% | -20.00% | -0% | -22.73% | +0% | -5.88% | -6.25% | -6.67% | +10.71% | -3.23% | +25% |
| 2023 | +3.85% | -7.41% | -36.00% | +56.25% | +0% | +12% | -3.57% | +11.11% | -13.33% | -11.54% | +8.70% | -4.00% | -7.69% |
| 2022 | -21.67% | -8.51% | +32.56% | -33.33% | +44.74% | -29.09% | -20.51% | -12.90% | +18.52% | -9.38% | +13.79% | -21.21% | -56.67% |
| 2021 | +2.72% | -10.61% | +25.85% | -11.11% | -28.79% | -17.55% | -13.55% | +10.45% | -11.49% | -32.82% | -15.91% | -18.92% | -76.65% |
| 2020 | +21.30% | -31.22% | -37.59% | +10.23% | +47.42% | -9.79% | +3.88% | -24.63% | -2.97% | -8.16% | +33.33% | +114.17% | +52.07% |
| 2019 | +1.13% | +36.87% | -20.82% | +12.89% | +2.74% | +5.78% | -51.26% | +2.59% | +15.13% | -5.84% | +22.48% | +6.96% | -4.52% |
| 2018 | +14.45% | -6.74% | -35.12% | -8.33% | +10.62% | -9.60% | -57.60% | -17.84% | -12.95% | -26.26% | -9.20% | -42.16% | -92.54% |
| 2017 | -46.66% | -12.52% | +57.15% | -6.05% | -9.69% | -29.60% | +6.53% | -4.76% | +25.01% | -20.01% | -8.98% | +14.24% | -53.79% |
Drawdown analysis of Regulus Therapeutics (RGLS)
The maximum drawdown for the RGLS was -99.97%, occurring on Mar 27, 2023. This drawdown has not yet recovered.
The current RGLS drawdown is -99.69%.
Since Oct 9, 2012 RGLS has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 2 times
- 20% or more: 3 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.97% | Nov 7, 2014 | 2108 | Mar 27, 2023 | Ongoing | Ongoing | Ongoing |
| -53.26% | Jul 11, 2013 | 208 | May 8, 2014 | 116 | Oct 22, 2014 | 324 |
| -25.98% | Jan 2, 2013 | 8 | Jan 14, 2013 | 40 | Mar 13, 2013 | 48 |
| -16.38% | Mar 28, 2013 | 23 | May 1, 2013 | 19 | May 29, 2013 | 42 |
| -15.76% | Oct 25, 2012 | 33 | Dec 14, 2012 | 3 | Dec 19, 2012 | 36 |
| -10.59% | Jun 21, 2013 | 3 | Jun 26, 2013 | 4 | Jul 2, 2013 | 7 |
| -6.27% | Nov 4, 2014 | 1 | Nov 5, 2014 | 2 | Nov 7, 2014 | 3 |
| -5.25% | Oct 9, 2012 | 1 | Oct 10, 2012 | 6 | Oct 18, 2012 | 7 |
| -4.66% | Oct 27, 2014 | 1 | Oct 28, 2014 | 3 | Oct 31, 2014 | 4 |
| -4.43% | Mar 20, 2013 | 1 | Mar 21, 2013 | 1 | Mar 22, 2013 | 2 |
| -1.99% | Jun 13, 2013 | 2 | Jun 17, 2013 | 3 | Jun 20, 2013 | 5 |
| -1.62% | Jun 3, 2013 | 2 | Jun 5, 2013 | 3 | Jun 10, 2013 | 5 |
| -0.96% | Dec 20, 2012 | 2 | Dec 24, 2012 | 2 | Dec 27, 2012 | 4 |
| -0.74% | Mar 15, 2013 | 2 | Mar 19, 2013 | 1 | Mar 20, 2013 | 3 |
| -0.30% | Mar 13, 2013 | 1 | Mar 14, 2013 | 1 | Mar 15, 2013 | 2 |